Table of contents: VOL. 149, NO. 5 - March 8, 2004
Eisner's Last Act Disney's CEO will have to turn in a star performance to prevent a takeover, placate shareholders, and repair ABC. Plus: Comcast's waiting game.
Biology's Bad Boy Is Back Craig Venter brought us the human genome. Now he aims to build a life form that will change the world.
Should We Admire Wal-Mart? Some say it's evil. Others insist it's a model of all that's right with America. Who are we to believe?
Southwest Airlines: The Hottest Thing in the Sky Through change at the top, through 9/11, in a lousy industry, it keeps winning Most Admired kudos. How?
The New Drug War Pharmaceutical companies need profits to develop new drugs. Patients need pills that they can afford. Their interests are colliding at the Canadian border.
Teacher's Bet A former professor at Harvard Business School, Gary Loveman is taking Las Vegas to school. As the CEO of Harrah's, he's building what will soon be the U.S.'s largest gaming company--all by simply treating gamblers as shoppers. By Julie Schlosser
Caught in the Crossfire It's the largest rebuilding project since the Marshall Plan. But for Bechtel, Halliburton, and other American companies that have been fired on by rebels, sniped at by politicians, and sabotaged by looters, it's also the most dangerous.
Finally, A Cure For Shooting Pains Digital camera companies seem ready to end the megapixel wars. Their new campaign: building cameras and printers even Luddites can love.
Trinkaus: An Informal Look For this business professor, the mysteries of human behavior are subjects to be quantified. And that is all.
Consider your options Changes in the rules on expensing stock options could alter the value of many tech stocks.
Hooking the Next Winner Comcast's Disney bid is the latest--but not the last--in a wave of deals. Here's how to profit from the media merger game.